
ASSOCIATION OF THE –308 (G->A) POLYMORPHISM OF TUMOR NECROSIS FACTOR α WITH MYOCARDIAL INFARCTION AND SUDDEN CARDIAC DEATH Tulyakova G1,*, Nasibullin T1, Salmanov A2, Avzaletdinova D1,
Khusnutdinova E1, Zakirova A3, Mustafina O1 *Corresponding Author: Dr. Gulnara Tulyakova, Institute of Biochemistry and Genetics, Ufa Research Center, Russian Academy of Sciences, October Avenue 69, 450054, Ufa, Bashkortostan, Russia; Tel.: +7-3472-361176; Fax: +7-3472-356100; E-mail: gulnarat@mail.ru page: 31
|
Abstract
Inflammation plays an important role in the pathogenesis of atherosclerosis. This study looked for a possible association of the –308 (G->α) polymorphism of tumor necrosis factor-α (TNF-α), a pro-inflammatory cytokine, with myocardial infarction and sudden cardiac death (SCD). The polymorphism was studied by a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method in 306 male patients with myocardial infarction (MI), 149 individuals with SCD and 245 healthy controls. The frequency of TNFA1 allele was 84.96% in the control group, 89.05% in the patients with MI, and 82.89% in the individuals with SCD, and of the TNFA2 allele 15.04, 10.95 and 17.11%, respectively. No significant differences in the genotype and allele frequencies were found between the study groups and the healthy control individuals. But, in the patients with MI and those with SCD, the frequencies of the TNFA2 allele (17.11 vs. 10.95%, p = 0.007) and theTNFA1/2 genotype (34.23 vs. 19.93%, p = 0.001) in the group with SCD were significantly higher. We conclude that the –308 (G->α) polymorphism of the TNF-α gene is not associated with MI or SCD in the male population of Bashkortostan, but may be a marker of SCD in patients with coronary artery disease. Key words: Atherosclerosis, Gene, Myocardial infarction (MI), Polymorphism, Tumor necrosis factor-α (TNF-α).
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|